Showing 3291-3300 of 5773 results for "".
- Baxter Launches Digital Image Capture Capability of Panoptic Plus Ophthalmoscopehttps://modernod.com/news/baxter-launches-digital-image-capture-capability-of-panoptic-plus-ophthalmoscope/2481891/Baxter International announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope. The iExaminer Pro System adds a key technology to routine eye exams, designed to help advance healthcare professio
- Sight Sciences Presents Phase 1 Results of the SAHARA Trial Comparing TearCare to Restasis for the Treatment of Dry Eye Diseasehttps://modernod.com/news/sight-sciences-presents-phase-1-results-of-the-sahara-trial-comparing-tearcare-to-restasis-for-the-treatment-of-dry-eye-disease/2481888/Sight Sciences announced the presentation of the full phase 1 results from the SAHARA randomized controlled trial, demonstrating that interventional eyelid procedures for dry eye disease enabled by TearCare technology were superior at all measured time points to Restasis prescription eye dro
- Alcon Showcases New TOTAL30 Multifocal Lenses and Other Innovations at #Academy23https://modernod.com/news/alcon-demonstrates-commitment-to-innovation-at-academy23-showcasing-total30-multifocal/2481884/Alcon will introduce TOTAL30 Multifocal, the first and only reusable Water Gradient multifocal contact lens, along with the latest advancements in eye care technology at the American Academy of Optometry Annual Meeting (#Academy23) in New Orleans, October 11-14, 2023. Alcon&rs
- Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopiahttps://modernod.com/news/alcon-launches-total30-multifocal-contact-lenses-for-patients-with-presbyopia/2481879/Alcon announced the global launch of TOTAL30 Multifocal, the first and only monthly water gradient multifocal contact lens, according to Alcon. The lenses have begun to roll out in the United States and in select international markets. Many lens wearers stop wearing contact le
- Genentech’s Vabysmo Maintained Vision Improvements With Extended Treatment Intervals Up to 4 Months for People with RVO in Phase 3 Trialshttps://modernod.com/news/genentechs-vabysmo-maintained-vision-improvements-with-extended-treatment-intervals-up-to-4-months-for-people-with-rvo-in-phase-3-trials/2481878/Genentech announced positive topline long-term results from the global phase 3 BALATON and COMINO studies evaluating extended treatment intervals with Vabysmo (faricimab-svoa) in macular edema due to branch and central retinal vein occlusion (BRVO and CRVO). From weeks 24 to 7
- Phase 3 Stage 1 DIAMOND Trial Results of Oculis' OCS-01 in DME Presented at Euretinahttps://modernod.com/news/phase-3-stage-1-diamond-trial-results-of-oculis-ocs-01-in-dme-presented-euretina/2481877/Oculis announced that Professor Ramin Tadayoni, MD, PhD, presented the positive results from stage 1 of the phase 3 DIAMOND trial of OCS-01 in patients with DME at the 23rd EURETINA congress in Amsterdam. The data showed that the trial met primary and secondary endpoints
- AEYE Health Makes Its One-Image-Per-Eye Diabetic Eye Exam Faster by Cutting Processing Time to Under 5 Secondshttps://modernod.com/news/aeye-health-makes-its-one-image-per-eye-diabetic-eye-exam-faster-by-cutting-processing-time-to-under-5-seconds/2481874/AEYE Health, a provider of AI-based diabetic retinopathy (DR) screening, announced that it has reduced the processing time for its AEYE-DS diabetic retinopathy screening system to under 5 seconds. This improvement is the result of smarter utilization of computing resources that accelerate th
- Two-Year Results of Eylea HD (Aflibercept 8 mg) from PULSAR Trial for Wet AMD Presented at Euretinahttps://modernod.com/news/two-year-results-of-eylea-hd-aflibercept-8-mg-from-pulsar-trial-presented-at-euretina/2481870/Regeneron announced the first presentation of positive 2-year (96 weeks) results from the PULSAR trial investigating Eylea HD (aflibercept) injection 8 mg with 12- and 16-week dosing regimens, compared to Eylea (aflibercept) injection, in patients with wet age-related macular degenerati
- Bausch + Lomb Launches New Range of Pure‐Line Gases at Euretinahttps://modernod.com/news/bausch-lomb-launches-new-range-of-pureline-gases-at-euretina-1/2481869/Bausch + Lomb announced the European launch of the new range of Pure‐line gases during the European Society of Retina Specialists (Euretina) annual meeting, taking place in Amsterdam, The Netherlands, Oct. 5‐ 8, 2023. Designed for ease of use, the Pure‐line gases are available as both p
- Optometry Giving Sight Sets $500,000 Fundraising Goal for the 2023 World Sight Day Challengehttps://modernod.com/news/optometry-giving-sight-sets-500000-fundraising-goal-for-the-2023-world-sight-day-challenge/2481868/Optometry Giving Sight (OGS) has announced a $500,000 fundraising goal for its 2023 World Sight Day Challenge. Donations will fuel the organization’s efforts to help eradicate uncorrected refractive error through the growth and expansion of optometry around the world. The the